| 1 |
35150639 | Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry. | 2022 Mar 1 |
4 |
| 2 |
35220926 | In silico and in vitro evaluation of imatinib as an inhibitor for SARS-CoV-2. | 2022 Feb 26 |
1 |
| 3 |
35388061 | Imatinib inhibits SARS-CoV-2 infection by an off-target-mechanism. | 2022 Apr 6 |
1 |
| 4 |
33294307 | Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study. | 2021 |
1 |
| 5 |
34203261 | Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles. | 2021 Jun 28 |
3 |